MedTrace Logo

Study Comparing Peri-articular Injection of Bupivacaine With and Without Epinephrine

NCT00737139 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2012-08-31

No results posted yet for this study

Summary

This study involves research. The purpose of this research is to formally investigate the hemostatic efficacy of epinephrine to minimize blood loss after total joint arthroplasty. It is unclear if using intra-articular injections of epinephrine in total joint replacement is associated with a decrease in post-operative blood loss. The initial hypothesis is: the use of intra-articular injection of epinephrine is associated with decreased post-operative blood loss.

Conditions

Interventions

PROCEDURE

Peri-articular injection of marcaine/epinephrine

60ml of 0.5% Bupivacaine and Epinephrine 1:200,000 Inj

PROCEDURE

Peri-articular injection of marcaine alone

60ml of 0.5% Bupivacaine

Sponsors & Collaborators

  • Rush University Medical Center

    lead OTHER

Principal Investigators

  • Craig J. Della Valle, MD · Rush University Medical Center, Department of Orthopaedics

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2012-04-30
Completion
2012-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00737139 on ClinicalTrials.gov